Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Guido_Oelkers
|
| gptkbp:focusesOn |
immunology
hematology rare diseases |
| gptkbp:foundedYear |
1939
|
| gptkbp:fullName |
gptkb:Swedish_Orphan_Biovitrum_AB
|
| gptkbp:headquartersLocation |
gptkb:Stockholm,_Sweden
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sobi
|
| gptkbp:industry |
biopharmaceuticals
|
| gptkbp:listedOn |
gptkb:Nasdaq_Stockholm
|
| gptkbp:notableProduct |
gptkb:Alprolix
gptkb:Elocta gptkb:Kineret gptkb:Orfadin |
| gptkbp:numberOfEmployees |
~1,500
|
| gptkbp:stockSymbol |
gptkb:SOBI
|
| gptkbp:website |
https://www.sobi.com/
|
| gptkbp:bfsParent |
gptkb:Investor_AB
gptkb:PhRMA |
| gptkbp:bfsLayer |
6
|